Identification of potential diagnostic biomarkers for Parkinson's disease

  title={Identification of potential diagnostic biomarkers for Parkinson's disease},
  author={Feng Jiang and Qianqian Wu and Shuqian Sun and Guanghui Bi and Ling Guo},
  journal={FEBS Open Bio},
  pages={1460 - 1468}
The identification of biomarkers for early diagnosis of Parkinson's disease (PD) prior to the onset of symptoms may improve the effectiveness of therapy. To identify potential biomarkers, we downloaded microarray datasets of PD from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) between PD and normal control (NC) groups were obtained, and the feature selection procedure and classification model were used to identify optimal diagnostic gene biomarkers for PD. A total… 

A systems biology approach towards the identification of candidate therapeutic genes and potential biomarkers for Parkinson’s disease

The use of gene expression profiling of brain and blood for detecting valid targets and identifying early PD biomarkers is demonstrated and putative PD risk genes in brain, delineated biological processes and molecular functions that may be particularly disrupted in PD are discovered and several putativePD biomarkers in blood are identified.

Identification of biomarkers associated with Parkinson's disease by gene expression profiling studies and bioinformatics analysis

A combined mapping of several transcriptional evidences could establish a patient-specific signature for early diagnose of PD though eligible systems biology tools, which can also help develop effective drug-based therapeutic approaches.

Bioinformatics Approach to Identify Significant Biomarkers, Drug Targets Shared Between Parkinson’s Disease and Bipolar Disorder: A Pilot Study

A link between pathological processes of PD and BD is identified at transcriptional level and may help to predict the development of PD among the people suffering from BD and gives some clue to understand significant pathological mechanisms.

Identifying potential gene biomarkers for Parkinson’s disease through an information entropy based approach

This work used a publicly available substantia nigra microarray dataset, GSE20163, from NCBI GEO database, containing gene expression profiles for 10 PD patients and 18 normal controls and identified two gene communities that discriminated between the two groups with mean accuracy, and presented a considerable reduction in size compared to the initial network.

Inflammation and regulatory T cell genes are differentially expressed in peripheral blood mononuclear cells of Parkinson’s disease patients

Bioinformatics analysis showed an association between survival and inflammation genes and increased CD49d+ Treg ratios might signify the effort of the immune system to suppress ongoing neuroinflammation.

Dysregulated Long Non-coding RNAs in Parkinson’s Disease Contribute to the Apoptosis of Human Neuroblastoma Cells

Different expression profiles of lncRNA and mRNA in circulating leukocytes between PD patients and healthy controls are identified, revealing biological pathways related to PD pathogenesis, including immune response, inflammatory response, MAPK, and Jak-STAT pathway.

A Machine Learning Approach to Parkinson’s Disease Blood Transcriptomics

This work used transcriptome data from the PPMI study, a large cohort study with early PD subjects and age matched controls, to perform the classification of PD vs. HC in around 550 samples and found 493 candidate genes.

Transcriptome Profiling Reveals Differential Expression of Circadian Behavior Genes in Peripheral Blood of Monozygotic Twins Discordant for Parkinson’s Disease

A transcriptome analysis of the peripheral blood of three pairs of monozygotic twins discordant for PD identified the metabolic process “circadian behavior” as a priority process for further study and found increased expression of three genes associated with circadian behavior in twins with PD.



Integrated Analysis and Identification of Novel Biomarkers in Parkinson’s Disease

It is suggested that five significantly downregulated mRNAs and three significantly down regulated miRNAs were potentially useful diagnostic markers in clinic, and lipid metabolism (especially non-alcoholic fatty liver disease pathway) and mitochondrial dysregulation may be the keys to biochemically detectable molecular defects.

Molecular markers of early Parkinson's disease based on gene expression in blood

Gene expression signals measured in blood can facilitate the development of biomarkers for PD, and the molecular multigene marker here identified is associated with risk of PD in 66 samples of the training set comprising healthy and disease controls.

Blood transcriptomics of drug-naïve sporadic Parkinson’s disease patients

Gene expression profiling of blood samples discriminates PD patients from healthy controls and identifies differentially expressed genes in blood suggesting epigenetics as target for therapeutic intervention supports the use of blood transcriptomics to study neurodegenerative diseases.

Analysis of blood-based gene expression in idiopathic Parkinson disease

This work identifies a reliable blood-based PD signature and highlights the importance of large-scale patient cohorts in developing potential PD biomarkers.

Convergence of miRNA Expression Profiling, α-Synuclein Interacton and GWAS in Parkinson's Disease

Findings suggest that several miRNAs may act as regulators of both known and novel biological processes leading to idiopathic PD, as well as novel pathways previously linked to PD.

microRNA Profiles in Parkinson's Disease Prefrontal Cortex

Based on cortical miRNA levels, PD brains were accurately classified from non-diseased brains and the PDD miRNA profile exhibited a more severe pattern of alteration among those differentially expressed in PD.

The medial and lateral substantia nigra in Parkinson’s disease: mRNA profiles associated with higher brain tissue vulnerability

The view that glial cells can be primarily affected in PD is supported, emphasizing the importance of using a whole tissue approach when investigating degenerative CNS disease.

Methodological considerations for gene expression profiling of human brain

Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes

The presented dynamic networks provide a novel avenue for identifying disease and treatment-related therapeutic targets and are a major step forward in the road for understanding the molecular basis for neurological and neurodegenerative diseases and assessment of the impact of brain stimulation on human diseases.